Holger Kirchner
National Institutes of Health
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Holger Kirchner.
Contemporary topics in immunobiology | 1980
Ronald B. Herberman; Howard T. Holden; Luigi Varesio; Tadayoshi Taniyama; Paolo Puccetti; Holger Kirchner; James M. Gerson; Sandra White; Yona Keisari; J. Stephen Haskill
There have been many studies of immune responses against tumors and almost all of these have focused on the reactivity in the blood or spleen. From such studies, it has become clear that a wide variety of effector cells and types of immune functions may be involved in antitumor responses. Particular attention has been directed toward T cells that may be directly cytotoxic against tumor cells or may proliferate or produce lymphokines upon stimulation with tumor antigens. However, other effector mechanisms may be involved and need to be considered. These include B cells, which can produce antibodies that affect tumor cells directly or that interact with K cells or macrophages and thereby mediate antibody-dependent cell-mediated cytotoxicity; macrophages and monocytes, which are spontaneously cytotoxic or can be activated to become cytotoxic against tumor cells; and natural killer (NK) cells, a subpopulation of lymphocytes with spontaneous cytotoxic reactivity against tumor cells.
Experimental Biology and Medicine | 1978
Holger Kirchner; Hans Martin Hirt; David L. Rosenstreich; Stephan E. Mergenhagen
Summary In vitro replication of herpes simplex virus (HSV) in murine spleen cells requires simultaneous cell stimulation with a B-cell mitogen such as lipopolysaccharide (LPS). As expected, spleen cells of LPS-unresponsive C3H/HeJ mice did not support HSV replication in LPS-pretreated cultures, while spleen cells from closely related but LPS-responsive C3HeB/FeJ did. More importantly, the C3H/HeJ strain was found to be intrinsically resistant to HSV infection in vivo. After intraperitoneal (ip) inoculation, HSV was 50-120 times more virulent for C3HeB/FeJ mice than for the C3H/HeJ strain. This resistance appeared to be due to a failure of HSV to replicate in C3H/HeJ peritoneal cells, since after ip infection with HSV, recovery of virus was higher and more consistent from peritoneal exudate cells of C3HeB/FeJ mice than from C3H/HeJ mice. In addition, no difference in lethality was observed between these two strains after a direct intracerebral inoculation of HSV. This observation that LPS-unresponsive mice are intrinsically resistant to lethal HSV infection, coupled with the LPS requirement for HSV replication in vitro, suggests an important but as yet unexplained link between host sensitivity to HSV and to LPS.
Journal of Experimental Medicine | 1974
Holger Kirchner; Thomas M. Chused; Ronald B. Herberman; Howard T. Holden; D. H. Lavrin
Journal of Immunology | 1975
Holger Kirchner; Andrew V. Muchmore; Thomas M. Chused; Howard T. Holden; Ronald B. Herberman
Journal of Immunology | 1979
Holger Kirchner; Giovanna Tosato; R. Michael Blaese; Samuel Broder; Ian Magrath
Journal of Immunology | 1975
Holger Kirchner; Howard T. Holden; Ronald B. Herberman
Journal of Immunology | 1976
Howard T. Holden; J S Haskill; Holger Kirchner; Ronald B. Herberman
Nature | 1975
Holger Kirchner; Moshe Glaser; Ronald B. Herberman
International Journal of Cancer | 1975
Moshe Glaser; Holger Kirchner; Ronald B. Herberman
Journal of the National Cancer Institute | 1975
Holger Kirchner; Howard T. Holden; Ronald B. Herberman